Physician profile
Michael Murri
NPI 1649768532
$3,276.65
in general payments reported to CMS, 2019-2025
19 companies · $1,389 in 2025
The $1,389 reported for 2025 was more than what 79% of Cornea and External Diseases Specialist providers received nationally (typical 2025 total: $477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.50 · 2021: $167 · 2022: $305 · 2023: $439 · 2024: $954 · 2025: $1,389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,782.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $953.11 | 2019-2025 | Hydrus Microstent, Clareon, Precision 1 |
| Glaukos Corporation | $601.03 | 2024-2025 | Photrexa Viscous and Photrexa, Kxl System (Not Refurbished), Istent Trabecular Micro-Bypass System Model Is3 |
| Johnson & Johnson Surgical Vision, INC. | $291.65 | 2023-2025 | Veritas Vision System, Tecnis Simplicity, Tecnis Iol |
| Abbvie INC. | $230.06 | 2024-2025 | |
| Ocular Therapeutix, INC. | $173.47 | 2021-2023 | Dextenza |
| Harrow Eye, LLC | $168.21 | 2024-2025 | Iheezo |
| Genentech USA, INC. | $166.08 | 2024 | Vabysmo |
| Oyster Point Pharma, INC. | $118.77 | 2022 | |
| Rxsight INC | $96.45 | 2024-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Bausch & Lomb Americas INC. | $78.91 | 2022-2024 | Envista Mx60 Iol, Alden Scleral Zenlens |
| Tarsus Pharmaceuticals, INC. | $78.23 | 2024 | Xdemvy |
| New World Medical,INC. | $65.59 | 2024 | Clearpath, Streamline, Kahook Dual Blade |
| Allergan, INC. | $46.58 | 2021 | |
| Astellas Pharma US INC | $39.65 | 2023-2025 | Izervay |
| Sight Sciences, INC. | $37.10 | 2021-2024 | Omni Surgical System |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyepoint US, INC. | $35.02 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $34.80 | 2025 | Eylea Hd |
| Dompe US, INC. | $31.96 | 2025 | Oxervate |
| Coopervision INC. | $29.98 | 2024 | Myday Contact Lens |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Murri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.